Cinctive Capital Management’s Wells Fargo WFC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,950
Closed -$247K 539
2025
Q3
$247K Sell
2,950
-60,923
-95% -$4.94M 0.01% 375
2025
Q2
$5.12M Sell
63,873
-164,102
-72% -$11.8M 0.27% 131
2025
Q1
$16.4M Sell
227,975
-15,934
-7% -$1.2M 1.25% 17
2024
Q4
$17.1M Buy
+243,909
New +$16.7M 0.87% 21
2024
Q3
Sell
-422,050
Closed -$25.1M 532
2024
Q2
$25.1M Buy
422,050
+394,698
+1,443% +$23.3M 1.19% 6
2024
Q1
$1.59M Buy
+27,352
New +$1.43M 0.07% 238
2023
Q4
Sell
-124,890
Closed -$5.1M 514
2023
Q3
$5.1M Buy
+124,890
New +$5.39M 0.25% 135
2023
Q2
Sell
-144,290
Closed -$5.39M 527
2023
Q1
$5.39M Sell
144,290
-401,511
-74% -$17.5M 0.18% 190
2022
Q4
$22.5M Buy
545,801
+101,938
+23% +$4.51M 1.1% 11
2022
Q3
$17.9M Buy
443,863
+165,874
+60% +$7.13M 0.75% 16
2022
Q2
$10.9M Buy
277,989
+92,365
+50% +$4.05M 0.46% 49
2022
Q1
$8.99M Buy
+185,624
New +$9.93M 0.33% 91
2021
Q4
Sell
-111,751
Closed -$5.19M 668
2021
Q3
$5.19M Buy
+111,751
New +$5.17M 0.25% 130

Other funds holding WFC

Cinctive Capital Management's WFC Position: Q4 2025 in Review

Cinctive Capital Management sold out of Wells Fargo (WFC) in Q4 2025, closing a stake of 2,950 shares — an estimated $247K sold.

Cinctive Capital Management first reported a position in WFC in Q3 2021 and held it in 13 quarters. The position peaked at $25.1M in Q2 2024. 2,906 funds tracked by Wall St. Rank hold WFC as of Q4 2025.

  • Cinctive Capital Management reported no remaining Wells Fargo position as of Q4 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 2,950 Wells Fargo shares in Q4 2025, an estimated $247K.
  • Cinctive Capital Management first reported a position in Wells Fargo in Q3 2021 and held it in 13 quarters.
  • Cinctive Capital Management's Wells Fargo position peaked at $25.1M in Q2 2024.
  • 2,906 funds tracked by Wall St. Rank held Wells Fargo as of Q4 2025.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.